Behind the Scenes of Edwards Lifesciences's Latest Options Trends

Investors with a lot of money to spend have taken a bullish stance on Edwards Lifesciences EW.

And retail traders should know.

We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.

Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with EW, it often means somebody knows something is about to happen.

Today, Benzinga's options scanner spotted 10 options trades for Edwards Lifesciences.

This isn't normal.

The overall sentiment of these big-money traders is split between 50% bullish and 50%, bearish.

Out of all of the options we uncovered, there was 1 put, for a total amount of $86,950, and 9, calls, for a total amount of $1,565,321.

What's The Price Target?

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $62.5 to $90.0 for Edwards Lifesciences over the recent three months.

Volume & Open Interest Development

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Edwards Lifesciences's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Edwards Lifesciences's whale trades within a strike price range from $62.5 to $90.0 in the last 30 days.

Edwards Lifesciences 30-Day Option Volume & Interest Snapshot

Biggest Options Spotted:

About Edwards Lifesciences

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US

Present Market Standing of Edwards Lifesciences

• Currently trading with a volume of 2,372,987, the EW's price is down by -0.94%, now at $93.79.
• RSI readings suggest the stock is currently may be approaching overbought.
• Anticipated earnings release is in 33 days.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Edwards Lifesciences, Benzinga Pro gives you real-time options trades alerts.